| 1. |
Chourasia N, Maheshwari A, Kalamangalam G. Cognitive and functional status in late-onset Lennox–Gastaut syndrome: variation on a classic phenotype. Epilepsy & Behavior, 2020, 102: 106660.
|
| 2. |
季濤云, 姜玉武, 蔣莉, 等. Lennox-Gastaut綜合征診斷治療的中國專家共識. 癲癇雜志, 2022, 8(3): 187-195.
|
| 3. |
Mastrangelo M. Lennox–gastaut syndrome: a state of the art review. Neuropediatrics, 2017, 48(3): 143-151.
|
| 4. |
Shandra O, Moshé SL, Galanopoulou AS. Inflammation in epileptic encephalopathies. Advances in Protein Chemistry and Structural Biology, 2017, 108: 59-84.
|
| 5. |
Asadi-Pooya AA. Lennox-Gastaut syndrome: a comprehensive review. Neurological Sciences, 2018, 39(3): 403-414.
|
| 6. |
宮玉哲, 王天成. Lennox-Gastaut綜合征相關致病基因研究進展. 山東醫藥, 2020, 60(20): 94-97.
|
| 7. |
Bourgeois BFD, Douglass LM, Sankar R. Lennox-Gastaut syndrome: a consensus approach to differential diagnosis. Epilepsia, 2014, 55: 4-9.
|
| 8. |
Resnick T, Sheth RD. Early diagnosis and treatment of Lennox-Gastaut Syndrome. Journal of Child Neurology, 2017, 32(11): 947-955.
|
| 9. |
Yamatogi Y, Ohtsuka Y, Ishida T, et al. Treatment of the Lennox syndrome with ACTH: a clinical and electroencephalographic study. Brain & Development (Tokyo. 1979), 1979, 1(4): 267-76.
|
| 10. |
黃鐵栓, 朱金蘭, 胡雁, 等. 甲基潑尼松龍沖擊治療Lennox-Gastaut綜合征合并睡眠期癲癎性腦電持續狀態. 中國當代兒科雜志, 2005, (3): 231-232.
|
| 11. |
滕雪寶, 袁寶強, 雍曾花, 等. 大劑量激素沖擊治療57例難治性癲癇的療效觀察. 中華臨床醫師雜志(電子版), 2017, 11(7): 1103-1106.
|
| 12. |
Sinclair DB. Prednisone therapy in pediatric epilepsy. Pediatric Neurology, 2003, 28(3): 194-198.
|
| 13. |
You SJ, Jung DE, Kim HD, et al. Efficacy and prognosis of a short course of prednisolone therapy for pediatric epilepsy. European Journal of Paediatric Neurology, 2008, 12(4): 314-320.
|
| 14. |
Smeraldi E, Smeraldi RS, Cazzullo CL, et al. Immunogenetics of the Lennox‐Gastaut Syndrome: Frequency of hl‐a antigens and haplotypes in patients and first‐degree relatives. Epilepsia, 1975, 16(5): 699-703.
|
| 15. |
van Engelen BG, de Waal LP, Weemaes CM, et al. Serologic HLA typing in cryptogenic Lennox-Gastaut syndrome. Epilepsy research, 1994, 17(1): 43-47.
|
| 16. |
van Engelen BG, Weemaes CM, Renier WO, et al. A dysbalanced immune system in cryptogenic Lennox-Gastaut syndrome. Scand J Immunol, 1995, 41(2): 209-213.
|
| 17. |
Mota NG, Rezkallah-Iwasso MT, Pera?oli M T, et al. Demonstration of antibody and cellular immune response to brain extract in West and Lennox-Gastaut syndromes. Arquivos de Neuro-psiquiatria, 1984, 42(2): 126-131.
|
| 18. |
Haraldsson A, van Engelen BG, Renier WO, et al. Light chain ratios and concentrations of serum immunoglobulins in children with epilepsy. Epilepsy Research, 1992, 13(3): 255-60.
|
| 19. |
Carvalho KS, Walleigh DJ, Legido A. Generalized epilepsies: immunologic and inflammatory mechanisms. Seminars in Pediatric Neurology, 2014, 21(3): 214-220.
|
| 20. |
Papadopoulou-Alataki E, Garganis K, Dalpa E, et al. Intavenous immunoglobulin for the management of intractable epilepsy in a boy. Hippokratia, 2017, 21(1): 55-57.
|
| 21. |
Vezzani A. Brain inflammation and seizures: evolving concepts and new findings in the last 2 decades. Epilepsy Curr, 2020, 20(suppl 6): 40-43.
|
| 22. |
陳輝, 鐘建民, 易招師, 等. 潑尼松治療嬰兒痙攣癥的免疫機制研究. 中國當代兒科雜志, 2017, 19(10): 1044-1050.
|
| 23. |
Kendall DA, McEwen BS, Enna SJ. The influence of ACTH and corticosterone on [3H]GABA receptor binding in rat brain. Brain Res. 1982;236(2): 365-374.
|
| 24. |
Vreugdenhil E, de Kloet E R, Schaaf M, et al. Genetic dissection of corticosterone receptor function in the rat hippocampus. Eur Neuropsychopharmacol, 2001, 11(6): 423-430.
|
| 25. |
Huttenlocher PR, Amemiya IM. Effects of adrenocortical steroids and of adrenocorticotrophic hormone on (Na+-K+)-ATPase in immature cerebral cortex. Pediatr Res, 1978, 12(2): 104-107.
|
| 26. |
Molteni R, Fumagalli F, Magnaghi V, et al. Modulation of fibroblast growth factor-2 by stress and corticosteroids: from developmental events to adult brain plasticity. Brain Res Brain Res Rev, 2001, 37(1-3): 249-258.
|
| 27. |
Bagla S, Dombkowski AA. Neuroinflammatory nexus of pediatric epilepsy. J Pediatr Epilepsy, 2018, 7(2): 32-39.
|
| 28. |
Vidal C, Jordan W, Zieglgansberger W. Corticosterone reduces the excitability of hippocampal pyramidal cells in vitro. Brain Res, 1986, 383(1-2): 54-59.
|
| 29. |
Joels M. Corticosteroid actions in the hippocampus. J Neuroendocrinol, 2001, 13(8): 657-669.
|
| 30. |
Pera MC, Randazzo G, Masnada S, et al. Intravenous methylprednisolone pulse therapy for children with epileptic encephalopathy. Funct Neurol, 2015, 30(3): 173-179.
|
| 31. |
Strzelczyk A, Schubert-Bast S. Expanding the treatment landscape for lennox-gastaut syndrome: current and future strategies. CNS Drugs, 2021, 35(1): 61-83.
|
| 32. |
Na JH, Kim HD, Lee YM. Effective and safe diet therapies for Lennox-Gastaut syndrome with mitochondrial dysfunction. Ther Adv Neurol Disord, 2020, 13: 1756286419897813.
|
| 33. |
Dibué M, Greco T, Spoor JKH, et al. Vagus nerve stimulation in patients with Lennox-Gastaut syndrome: a meta-analysis. Acta Neurol Scand, 2021, 143(5): 497-508.
|
| 34. |
宮玉哲, 王天成. Lennox-Gastaut綜合征治療研究進展. 醫學綜述, 2020, 26(9): 1802-1807.
|
| 35. |
Schmidt D, Bourgeois B. A risk-benefit assessment of therapies for Lennox-Gastaut syndrome. Drug Saf, 2000, 22(6): 467-477.
|
| 36. |
Klein RLS. The effect of adrenocorticotropic hormone in epilepsy. J Pediatr, 1950, 37: 733-742.
|
| 37. |
Charuvanij A, Ouvrier RA, Procopis PG, et al. ACTH treatment in intractable seizures of childhood. Brain Dev, 1992, 14(2): 102-106.
|
| 38. |
Haberlandt E, Weger C, Sigl SB, et al. Adrenocorticotropic hormone versus pulsatile dexamethasone in the treatment of infantile epilepsy syndromes. Pediatr Neurol, 2010, 42(1): 21-27.
|
| 39. |
Yang D, Na J, Kim S H, et al. Efficacy and prognosis of long-term, high-dose steroid therapy for Lennox–Gastaut syndrome. Epilepsy Research, 2022, 179: 106847.
|
